Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$38.46 - $50.95 $46,152 - $61,140
-1,200 Reduced 17.14%
5,800 $281,000
Q1 2024

May 15, 2024

SELL
$37.48 - $44.74 $610,924 - $729,262
-16,300 Reduced 69.96%
7,000 $288,000
Q4 2023

Feb 14, 2024

SELL
$33.36 - $45.71 $90,072 - $123,417
-2,700 Reduced 10.38%
23,300 $1.04 Million
Q3 2023

Nov 14, 2023

BUY
$40.03 - $51.51 $464,348 - $597,516
11,600 Added 80.56%
26,000 $1.08 Million
Q2 2023

Aug 14, 2023

SELL
$40.45 - $48.0 $396,410 - $470,400
-9,800 Reduced 40.5%
14,400 $623,000
Q1 2023

May 15, 2023

BUY
$34.96 - $43.94 $527,896 - $663,494
15,100 Added 165.93%
24,200 $1.06 Million
Q4 2022

Feb 14, 2023

BUY
$36.55 - $51.15 $120,614 - $168,795
3,300 Added 56.9%
9,100 $332,000
Q3 2022

Nov 14, 2022

SELL
$47.75 - $66.88 $47,750 - $66,880
-1,000 Reduced 14.71%
5,800 $282,000
Q2 2022

Aug 15, 2022

SELL
$40.55 - $51.76 $24,330 - $31,056
-600 Reduced 8.11%
6,800 $335,000
Q1 2022

May 16, 2022

SELL
$36.56 - $50.98 $329,040 - $458,820
-9,000 Reduced 54.88%
7,400 $377,000
Q4 2021

Feb 14, 2022

SELL
$37.1 - $57.45 $793,940 - $1.23 Million
-21,400 Reduced 56.61%
16,400 $776,000
Q3 2021

Nov 15, 2021

BUY
$38.45 - $55.66 $449,865 - $651,222
11,700 Added 44.83%
37,800 $1.49 Million
Q2 2021

Aug 16, 2021

BUY
$49.67 - $68.96 $640,743 - $889,583
12,900 Added 97.73%
26,100 $1.43 Million
Q1 2021

May 17, 2021

BUY
$60.06 - $89.52 $792,792 - $1.18 Million
13,200 New
13,200 $835,000
Q1 2020

May 15, 2020

SELL
$26.79 - $38.99 $198,246 - $288,526
-7,400 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$29.07 - $35.63 $258,723 - $317,107
-8,900 Reduced 54.6%
7,400 $215,000
Q3 2019

Nov 14, 2019

BUY
$28.19 - $41.75 $459,497 - $680,525
16,300 New
16,300 $566,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $575M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.